It's probably the wise play/move to wait on some of these trials to wrap up this phase before doing an outright deal(on the whole company)so can't really be mad or blame anyone for that strategy , makes sense imo.

at the same time I wonder if it also makes sense to sell off  one part of the science to move rvx forward & at the same time fill zens account $$ until these trials finish up & beyond?

No more cheap(imo)PP's needed until well after these trials wrap up putting them in a better bargaining position for the real/big deal??

Guess it's possible we see something/a deal of sort's this year?